SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-22-012521
Filing Date
2022-07-07
Accepted
2022-07-07 16:19:14
Documents
80
Period of Report
2022-04-30

Document Format Files

Seq Description Document Type Size
1 10-K kalv-20220430.htm   iXBRL 10-K 2729032
2 EX-23.1 kalv-ex23_1.htm EX-23.1 3533
3 EX-31.1 kalv-ex31_1.htm EX-31.1 20865
4 EX-31.2 kalv-ex31_2.htm EX-31.2 16338
5 EX-32.1 kalv-ex32_1.htm EX-32.1 8547
6 EX-32.2 kalv-ex32_2.htm EX-32.2 11091
7 GRAPHIC img46125868_0.jpg GRAPHIC 52584
8 GRAPHIC img46125868_1.jpg GRAPHIC 57898
  Complete submission text file 0000950170-22-012521.txt   9497065

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kalv-20220430_lab.xml EX-101.LAB 432564
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kalv-20220430_pre.xml EX-101.PRE 306690
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kalv-20220430_cal.xml EX-101.CAL 60166
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kalv-20220430.xsd EX-101.SCH 47782
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kalv-20220430_def.xml EX-101.DEF 124656
74 EXTRACTED XBRL INSTANCE DOCUMENT kalv-20220430_htm.xml XML 1759900
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-K | Act: 34 | File No.: 001-36830 | Film No.: 221071850
SIC: 2834 Pharmaceutical Preparations